Indobufen-based dual antiplatelet therapy in patients undergoing PCI: a systematic review and meta-analysis

BackgroundConventional dual antiplatelet therapy (DAPT) post percutaneous coronary intervention (PCI) comprises aspirin and a P2Y12 inhibitor. However, aspirin increases gastrointestinal and bleeding risks. Indobufen, a reversible COX-1 inhibitor, may offer a safer alternative.ObjectivesTo evaluate...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Yiheng Liu, Bin Liu, Weiran Dai
Format:	Artigo
Sprog:	Inglês
Udgivet:	Frontiers Media S.A. 2026-07-01
Serier:	Frontiers in Pharmacology
Fag:	aspirin cardiovascular outcomes dual antiplatelet therapy indobufen major adverse cardiac events meta-analysis
Online adgang:	https://www.frontiersin.org/articles/10.3389/fphar.2026.1821883/full
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!